GNPX:NASDAQ, Genprex, Inc.

GNPX stock overview

Genprex, Inc. (GNPX:NASDAQ) closed at $1.81 on October 23, 2026, down 8.59% on the day. The stock trades 99.2% below its 52-week high of $222.20 and 1.1% above its 52-week low of $1.79. Over the past year, it lost 99.1%. Genprex, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$1.81
Day change
-8.59%
Volume
211,856
Average volume
273,031
Market cap
1M+
52-week range
$1.79 – $222.20
50-day average
$3.24
200-day average
$21.91

Price action over the past year

In 252 trading sessions since October 23, 2025, GNPX closed higher on 92 days (37%). Its best day was February 23, 2026 (+27.53%) and its worst was July 16, 2026 (-25.94%). The stock moved 10% or more in a single session 38 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

GNPX news

About Genprex, Inc.

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Similar stocks

Find more stocks like GNPX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.